Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject clinical trials

Explore recruiting not applicable submitted trial is a bioequivalence study in healthy subject clinical trials.

Also recruiting in Europe

Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril capsule, hard 10mg/5mg/5mg versus reference products Crestor 10 mg film coated tablets, Norvasc 5 mg tablets, Tritace 5 mg tablets in healthy male and female subjects under fasting conditions. Sponsor’s Study Number: ROS-AML-RAM-BIO-02-23

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject trials by city

Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Toronto Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Vancouver Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Montreal Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Calgary Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Edmonton Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Ottawa Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Winnipeg Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Quebec City Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Hamilton Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Kitchener Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in London Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Halifax Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in New York Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Los Angeles Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Chicago Not Applicable Submitted Trial Is A Bioequivalence Study In Healthy Subject in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease